+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe RNAi Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Molecule Type and MicroRNA , Application, Route of Administration, and End User and Country

  • ID: 5204955
  • Report
  • October 2020
  • Region: Europe
  • 136 pages
  • The Insight Partners
UP TO OFF
until Jan 31st 2021
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Sanofi
  • Silence Therapeutics
  • MORE
Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics in 2019

According to the new market research study on “Europe RNAi Therapeutics Market to 2027 - Regional Analysis and Forecast - by Molecule Type, Route of Administration, Application, and End User” the Europe RNAi therapeutics market is expected to reach US$324.33 million in 2027 from US$170.42 million in 2019, it is estimated to grow with a CAGR of 8.4% from 2020-2027. The report provides trends prevailing in the Europe RNAi therapeutics market and the factors driving the market growth along with those hindering it.

In 2019, the small interfering RNAs (siRNA) accounted for the highest share of the market. Growth of this segment is attributed to the increasing preference for small interfering RNAs for drug development and growing number of research partnerships. Furthermore, MicroRNA (miRNA) segment is expected to register higher CAGR in the RNAi therapeutics market during the forecast period.

The growth of the Europe RNAi therapeutics market is mainly attributed to growing prevalence of chronic conditions and rising investments for development of RNAi therapeutics. Additionally, increasing awareness about RNAi therapies and its benefits are anticipated to boost the research and innovations of RNAi therapeutics in the region will eventually drive the market growth. However, the high cost of RNAi therapy development is the major factor hindering the market growth in Europe.

Sanofi; GlaxoSmithKline plc; Silence Therapeutics; Alnylam Pharmaceuticals, Inc; and Arrowhead Pharmaceuticals, Inc are among the leading companies operating in the Europe RNAi therapeutics market.

The Report Segments Europe RNAi Therapeutics Market as Follows:

Europe RNAi Therapeutics Market - By Molecule Type
  • Small Interfering RNAs (siRNA)
  • MicroRNA (miRNA)
Europe RNAi Therapeutics Market - By Route of Administration
  • Pulmonary Delivery
  • Intravenous Injections
  • Intradermal Injections
  • Intraperitoneal Injections
  • Others
Europe RNAi Therapeutics Market - By Application
  • Oncology
  • Cardiovascular
  • Respiratory Disorders
  • Renal Diseases
  • Genetic Disorders
  • Neurodegenerative Disorders
  • Infectious Diseases
  • Others
Europe RNAi Therapeutics Market - By End User
  • Research and Academic Laboratories
  • Hospitals
  • Diagnostic Laboratories
Europe RNAi Therapeutics Market - By Country
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
Reasons to Buy
  • It provides an understanding of the Europe, RNAi therapeutics market landscape and identifies RNAi therapeutics market segments that are most likely to guarantee a strong return.
  • Stay ahead of the race by comprehending the ever-changing competitive landscape for the Europe RNAi therapeutics market.
  • It helps efficiently plan merger and acquisition, and partnership deals in the RNAi therapeutics market by identifying market segments with the most promising probable sales
  • It facilitates knowledgeable business decision-making through perceptive and comprehensive analysis of RNAi therapeutics market performance of various segments pertaining to the Europe RNAi therapeutics market.
  • It provides RNAi therapeutics market revenue forecast of the market based on various segments for the period from 2019 to 2027.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • GlaxoSmithKline plc
  • Sanofi
  • Silence Therapeutics
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe RNAi Therapeutics Market - By Molecule Type
1.3.2 Europe RNAi Therapeutics Market - By Application
1.3.3 Europe RNAi Therapeutics Market - By Route of Administration
1.3.4 Europe RNAi Therapeutics Market- By End User
1.3.5 Europe RNAi Therapeutics Market - By Country

2. Europe RNAi Therapeutics Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Europe RNAi Therapeutics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 RNAi therapeutics Market - Europe PEST Analysis
4.3 Expert Opinion

5. Europe RNAi Therapeutics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Growing Investments in RNAi Therapies
5.1.2 Rising Prevalence of Chronic Conditions and Infectious Diseases
5.2 Market Restraints
5.2.1 High Cost for RNAi Therapy Development
5.3 Market Opportunities
5.3.1 Significant Number of Pipeline Candidates for Strategic Alliances
5.4 Future Trends
5.4.1 Rising Emphasis on RNA Technologies
5.5 Impact analysis

6. RNAi Therapeutics Market - Europe Analysis
6.1 Europe RNAi Therapeutics Market Revenue Forecasts and Analysis

7. Europe RNAi Therapeutics Market Analysis and Forecasts To 2027 - By Molecule Type
7.1 Overview
7.2 Europe RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)
7.2.1 Europe RNAi therapeutics Market Revenue and Forecasts to 2027, By Molecule Type (US$ Mn)
7.3 Small Interfering RNAs (siRNA)
7.3.1 Overview
7.3.2 Europe Small Interfering RNAs (siRNA) Market Revenue and Forecast to 2027 (US$ Mn)
7.4 MicroRNA (miRNA)
7.4.1 Overview
7.4.2 Europe MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)

8. Europe RNAi therapeutics Market Analysis and Forecasts To 2027 - By Application
8.1 Overview
8.2 Europe RNAi therapeutics Market, By Application 2019 & 2027 (%)
8.2.1 Europe RNAi therapeutics Market Revenue and Forecasts to 2027, By Application (US$ Mn)
8.3 Genetic Disorders
8.3.1 Overview
8.3.2 Europe Genetic Disorders Market Revenue and Forecast to 2027 (US$ Mn)
8.4 Oncology
8.4.1 Overview
8.4.2 Europe Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
8.5 Neurodegenerative Disorders
8.5.1 Overview
8.5.2 Europe Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.6 Cardiovascular Disorders
8.6.1 Overview
8.6.2 Europe Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.7 Respiratory Disorders
8.7.1 Overview
8.7.2 Europe Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
8.8 Infectious Diseases
8.8.1 Overview
8.8.2 Europe Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.9 Renal Diseases
8.9.1 Overview
8.9.2 Europe Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
8.10 Other Disorders
8.10.1 Overview
8.10.2 Europe Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)

9. Europe RNAi therapeutics Market Analysis and Forecasts To 2027 - By Route of Administration
9.1 Overview
9.2 Europe RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)
9.2.1 Europe RNAi therapeutics Market Revenue and Forecasts to 2027, By Route of Administration (US$ Mn)
9.3 Intradermal Injections
9.3.1 Overview
9.3.2 Europe Intradermal Injections Market Revenue and Forecast to 2027 (US$ Mn)
9.4 Pulmonary Delivery
9.4.1 Overview
9.4.2 Europe Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
9.5 Intravenous Injections
9.5.1 Overview
9.5.2 Europe Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)
9.6 Intraperitoneal Injections
9.6.1 Overview
9.6.2 Europe Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
9.7 Other Route of Administrations
9.7.1 Overview
9.7.2 Europe Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)

10. Europe RNAi Therapeutics Market Analysis - By End-User
10.1 Overview
10.2 Europe RNAi Therapeutics Market, By End-User 2019-2027 (%)
10.2.1 Europe RNAi Therapeutics Market Revenue and Forecasts to 2027, By End-User (US$ Mn)
10.3 Diagnostic Laboratories
10.3.1 Overview
10.3.2 Europe Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
10.4 Research and Academic Laboratories
10.4.1 Overview
10.4.2 Europe Research and Academic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
10.5 Hospitals
10.5.1 Overview
10.5.2 Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)

11. RNAi therapeutics Market Revenue and Forecasts To 2027 - Geographical Analysis
11.1 Europe: RNAi Therapeutics Market
11.1.1 Overview
11.1.2 Europe: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 Europe RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.1.4 Europe RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.5 Europe RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.6 Europe RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.7 Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
11.1.8 Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 Germany RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.1.8.3 Germany RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.8.4 Germany RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.8.5 Germany RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.9 UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 UK RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.1.9.3 UK RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.9.4 UK RNAi Therapeutics Market, by Route of Administration- Revenue and Forecast to 2027 (USD Million)
11.1.9.5 UK: RNAi Therapeutics Market, End User - Revenue and Forecast to 2027 (USD Million)
11.1.10 France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 France RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.1.10.3 France RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.10.4 France RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.10.5 France RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.11 Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.1 Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.2 Spain RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.1.11.3 Spain RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.11.4 Spain RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.11.5 Spain RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
11.1.12 Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Italy RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
11.1.12.3 Italy RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
11.1.12.4 Italy RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
11.1.12.5 Italy RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)

12. Impact of COVID-19 Pandemic on Europe RNAi therapeutics Market
12.1 Europe: Impact Assessment of COVID-19 Pandemic

13. Company Profiles
13.1 Sanofi
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 GlaxoSmithKline plc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Silence Therapeutics
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Alnylam Pharmaceuticals, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Arrowhead Pharmaceuticals, Inc
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

List of Tables
Table 1. Europe RNAi therapeutics Market Revenue and Forecasts To 2027, By Molecule Type (US$ Mn)
Table 2. Europe RNAi therapeutics Market Revenue and Forecasts To 2027, By Application (US$ Mn)
Table 3. Europe RNAi therapeutics Market Revenue and Forecasts To 2027, By Route of Administration (US$ Mn)
Table 4. Europe RNAi Therapeutics Market Revenue and Forecasts To 2027, By End-User (US$ Mn)
Table 5. Europe RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 6. Europe RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 7. Europe RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 8. Europe RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 9. Germany RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Germany RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 11. Germany RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 12. Germany RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 13. United Kingdom RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 14. United Kingdom RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 15. UK: RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million).
Table 16. UK: RNAi Therapeutics Market, End User - Revenue and Forecast to 2027 (USD Million)
Table 17. France RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 18. France RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 19. France RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 20. France RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 21. Spain RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Spain RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 23. Spain RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 24. Spain RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 25. Italy RNAi Therapeutics Market, by Molecule Type - Revenue and Forecast to 2027 (USD Million)
Table 26. Italy RNAi Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 27. Italy RNAi Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 28. Italy RNAi Therapeutics Market, by End User - Revenue and Forecast to 2027 (USD Million)
Table 29. Glossary of Terms, RNAi Therapeutics Market

List of Figures
Figure 1. RNAi Therapeutics Market Segmentation
Figure 2. Europe RNAi Therapeutics Market Overview
Figure 3. Small Interfering RNAs (siRNA) Molecule Type Segment Held Largest Share of RNAi Therapeutics Market
Figure 4. UK is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Europe RNAi Therapeutics Market - Leading Country Markets (US$ Mn)
Figure 6. RNAi Therapeutics Market - Europe PEST Analysis
Figure 7. RNAi Therapeutics Market Impact Analysis of Driver and Restraints
Figure 8. Europe RNAi Therapeutics Market - Revenue Forecasts and Analysis - 2019-2027
Figure 9. Europe RNAi Therapeutics Market, By Molecule Type 2019 & 2027 (%)
Figure 10. Europe Small Interfering RNAs (siRNA) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 11. Europe MicroRNA (miRNA) Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 12. Europe RNAi therapeutics Market, By Application 2019 & 2027 (%)
Figure 13. Europe Genetic Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 14. Europe Oncology Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 15. Europe Neurodegenerative Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 16. Europe Cardiovascular Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 17. Europe Respiratory Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 18. Europe Infectious Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 19. Europe Renal Diseases Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 20. Europe Other Disorders Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 21. Europe RNAi therapeutics Market, By Route of Administration 2019 & 2027 (%)
Figure 22. Europe Intradermal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 23. Europe Pulmonary Delivery Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 24. Europe Intravenous Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 25. Europe Intraperitoneal Injections Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 26. Europe Other Route of Administrations Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 27. Europe RNAi Therapeutics Market, by End-User 2019 & 2027 (%)
Figure 28. Europe Diagnostic Laboratories Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 29. Europe Research and Academic Laboratories Mark et Revenue and Forecasts to 2027 (US$ Mn)
Figure 30. Europe Hospitals Market Revenue and Forecasts to 2027 (US$ Mn)
Figure 31. Europe: RNAi Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 32. Europe RNAi Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 33. Europe: RNAi Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 34. Germany: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. UK: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. France: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Spain: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Italy: RNAi Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in Europe Country Markets
Note: Product cover images may vary from those shown
3 of 3
  • Sanofi
  • GlaxoSmithKline plc
  • Silence Therapeutics
  • Alnylam Pharmaceuticals, Inc
  • Arrowhead Pharmaceuticals, Inc
Note: Product cover images may vary from those shown
Adroll
adroll